Latest news
Why ImmunityBio (IBRX) Is Up 6.6% After ANKTIVA’s UAE Expansion and Mixed Q2 Results – And What's Next - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:34:48 GMTIBRX Stock Rises Overnight: Investors Eye FDA Workshop On Anktiva After Exclusive Japan BCG Deal - stocktwits.comstocktwits.com · Sat, 08 Aug 2026 08:26:22 GMTIBRX Stock Extends 5-Day Losing Streak — Retail Traders Pin Hopes On ‘Incredibly Strong’ Anktiva Sales And Earnings Beat - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 15:44:53 GMTHow High Can IBRX Stock Go Now? Here’s What Wall Street Thinks After Saudi Nod For Bladder Cancer Filing - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 14:31:40 GMTIBRX Stock Reverses Pre-Market Gains After ANKTIVA Combo Shows Stronger Bladder Cancer Responses – Retail Sees Consolidation Before Next Leg Up - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 14:30:08 GMTIBRX Stock In Spotlight: ImmunityBio To Unveil Fresh Anktiva And BCG Data Next Week - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 14:26:19 GMTIBRX Founder Backs Trump’s Psychedelic Push In ‘Transforming’ Health Policy — Flags New Anktiva Breast Cancer Risk Data - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 11:57:05 GMTIBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 11:34:22 GMT